Oocyte meiotic spindle morphology is a predictive marker of blastocyst ploidy-a prospective cohort study.


Journal

Fertility and sterility
ISSN: 1556-5653
Titre abrégé: Fertil Steril
Pays: United States
ID NLM: 0372772

Informations de publication

Date de publication:
01 2020
Historique:
received: 28 05 2019
revised: 15 08 2019
accepted: 23 08 2019
pubmed: 20 11 2019
medline: 23 7 2020
entrez: 20 11 2019
Statut: ppublish

Résumé

To evaluate oocyte meiotic spindle (OMS) morphology at intracytoplasmic sperm injection (ICSI) as a predictor of blastocyst ploidy and whether OMS morphology could aid standard morphology-based blastocyst selection. Prospective cohort study. In vitro fertilization clinic. Patients undergoing ICSI cycles with an intention to perform preimplantation genetic testing for aneuploidy (PGT-A) from October 2014 to December 2017. The OMS was visualized with the use of polarized light microscopy at the time of ICSI and the morphology classified as normal, dysmorphic, translucent, not visible, or in telophase. Blastocyst biopsy for PGT-A was performed on embryos with suitable development. The association of OMS morphology with the resulting blastocyst ploidy was evaluated on an "intention-to-treat" (ITT) and an "as-treated analysis" (ATA) basis. The morphology of 2,056 OMSs were classified. A strong association of OMS morphology with fertilization, cleavage to at least 6 cells on day 3, and good/top-quality blastocyst formation was present. Normal OMS was positively associated with blastocyst euploidy compared with all other OMS types combined, per either ITT or ATA. Even after controlling for female age, blastocyst quality, and developmental stage, the presence of a normal OMS was strongly associated with the probability of blastocyst euploidy. OMS morphology is a predictive marker of blastocyst ploidy and can potentially aid standard morphology-based blastocyst selection.

Identifiants

pubmed: 31739977
pii: S0015-0282(19)32276-9
doi: 10.1016/j.fertnstert.2019.08.070
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105-113.e1

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

Liza Tilia (L)

School of Women's and Children's Health, University of New South Wales, Sydney, New South Wales, Australia; IVF Australia, Sydney, New South Wales, Australia. Electronic address: liza.tilia@ivf.com.au.

Michael Chapman (M)

School of Women's and Children's Health, University of New South Wales, Sydney, New South Wales, Australia; IVF Australia, Sydney, New South Wales, Australia.

Suha Kilani (S)

School of Women's and Children's Health, University of New South Wales, Sydney, New South Wales, Australia; IVF Australia, Sydney, New South Wales, Australia.

Simon Cooke (S)

School of Women's and Children's Health, University of New South Wales, Sydney, New South Wales, Australia; IVF Australia, Sydney, New South Wales, Australia.

Christos Venetis (C)

School of Women's and Children's Health, University of New South Wales, Sydney, New South Wales, Australia; Centre for Big Data Research in Health, University of New South Wales, Sydney, New South Wales, Australia; IVF Australia, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH